Gujarat Themis Biosyn Limited (BOM:506879)
India · Delayed Price · Currency is INR 355.10
+3.80 (1.08%)
At close: Oct 22, 2026
Gujarat Themis Biosyn Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 46,217 | 24,784 | 30,674 | 28,774 | 9,973 | 5,920 | |
Market Cap Growth | -7.36% | -19.20% | 6.60% | 188.53% | 68.46% | 100.07% |
Enterprise Value | 47,774 | 25,398 | 30,527 | 28,750 | 9,360 | 5,692 |
Last Close Price | 355.10 | 227.08 | 280.56 | 263.05 | 90.86 | 53.22 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 79.43 | 53.09 | 62.89 | 48.64 | 17.20 | 13.57 |
PS Ratio | 26.60 | 14.95 | 20.34 | 16.94 | 6.72 | 5.15 |
PB Ratio | 16.06 | 8.61 | 12.35 | 14.29 | 6.69 | 5.73 |
P/TBV Ratio | 16.07 | 8.62 | 12.36 | 14.29 | 6.69 | 5.73 |
P/FCF Ratio | - | - | - | - | 63.22 | 22.41 |
P/OCF Ratio | 94.75 | 50.81 | 33.70 | 44.81 | 25.26 | 14.68 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 27.50 | 15.32 | 20.24 | 16.93 | 6.31 | 4.96 |
EV/EBITDA Ratio | 57.80 | 34.17 | 44.62 | 37.07 | 12.69 | 9.81 |
EV/EBIT Ratio | 70.73 | 40.49 | 47.45 | 38.24 | 13.01 | 10.07 |
EV/FCF Ratio | - | - | - | - | 59.34 | 21.55 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.56 | 0.56 | 0.12 | 0.01 | 0.00 | 0.01 |
Debt / EBITDA Ratio | 1.96 | 2.14 | 0.44 | 0.03 | 0.01 | 0.02 |
Debt / FCF Ratio | - | - | - | - | 0.03 | 0.04 |
Net Debt / Equity Ratio | 0.54 | 0.55 | 0.08 | -0.06 | -0.06 | -0.20 |
Net Debt / EBITDA Ratio | 1.88 | 2.12 | 0.27 | -0.15 | -0.11 | -0.36 |
Net Debt / FCF Ratio | - | -1.27 | -0.75 | 1.09 | -0.54 | -0.78 |
Asset Turnover | - | 0.41 | 0.58 | 0.88 | 1.03 | 1.09 |
Inventory Turnover | - | 5.44 | 12.73 | 7.45 | 4.37 | 2.05 |
Quick Ratio | - | 0.83 | 2.10 | 2.58 | 1.81 | 2.82 |
Current Ratio | - | 1.12 | 2.53 | 2.94 | 4.04 | 4.57 |
Return on Equity (ROE) | - | 17.41% | 21.69% | 33.76% | 45.92% | 50.35% |
Return on Assets (ROA) | - | 9.74% | 15.39% | 24.25% | 31.13% | 33.53% |
Return on Invested Capital (ROIC) | 11.36% | 13.24% | 20.94% | 33.91% | 48.20% | 71.27% |
Return on Capital Employed (ROCE) | - | 14.80% | 22.90% | 36.70% | 47.60% | 53.70% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 21, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.26% | 1.88% | 1.59% | 2.06% | 5.81% | 7.37% |
FCF Yield | -2.68% | -4.99% | -0.82% | -0.36% | 1.58% | 4.46% |
Dividend Yield | 0.19% | 0.29% | 0.24% | 0.38% | 0.79% | 1.47% |
Payout Ratio | 14.99% | 15.64% | 3.72% | 11.67% | 21.45% | 6.55% |
Total Shareholder Return | 0.11% | 0.29% | 0.24% | 0.38% | 0.79% | 1.47% |